A1 Refereed original research article in a scientific journal

In-silico drug design for the novel Karachi-NF001 strain of brain-eating amoeba:Naegleria fowleri




AuthorsSaleem Tayyab, Jamal Syed Babar Jamal, Alzahrani Badr, Basheer Amina, Abbasi Sumra Wajid, Ali Mahwish, Rehman Ashfaq Ur, Faheem Muhammad

PublisherFRONTIERS MEDIA SA

Publishing placeLAUSANNE

Publication year2023

JournalFrontiers in Molecular Biosciences

Journal name in sourceFRONTIERS IN MOLECULAR BIOSCIENCES

Journal acronymFRONT MOL BIOSCI

Article number 1098217

Volume10

Number of pages9

eISSN2296-889X

DOIhttps://doi.org/10.3389/fmolb.2023.1098217

Web address https://doi.org/10.3389/fmolb.2023.1098217

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/386802606


Abstract
Naegleria fowleri (N. fowleri) is a free-living thermophilic amoeba of fresh water and soil. The amoeba primarily feeds on bacteria but can be transmitted to humans upon contact with freshwater sources. Furthermore, this brain-eating amoeba enters the human body through the nose and travels to the brain to cause primary amebic meningoencephalitis (PAM). N. fowleri has been reported globally since its discovery in 1961. Recently a new strain of N. fowleri named Karachi-NF001 was found in a patient who had traveled from Riyadh, Saudi Arabia to Karachi in 2019. There were 15 unique genes identified in the genome of the Karachi-NF001 strain compared to all the previously reported strains of N. fowleri worldwide. Six of these genes encode well-known proteins. In this study, we performed in-silico analysis on 5 of these 6 proteins, namely, Rab family small GTPase, NADH dehydrogenase subunit 11, two Glutamine-rich protein 2 proteins (locus tags: 12086 and 12110), and Tigger transposable element-derived protein 1. We conducted homology modeling of these 5 proteins followed by their active site identification. These proteins were subjected to molecular docking against 105 anti-bacterial ligand compounds as potential drugs. Subsequently, the 10 best-docked compounds were determined for each protein and ranked according to the number of interactions and their binding energies. The highest binding energy was recorded for the two Glutamine-rich protein 2 proteins with different locus tags, and results have shown that the protein-inhibitor complex was stable throughout the simulation run. Moreover, future in -vitro studies could validate the findings of our in-silico analysis and identify potential therapeutic drugs against N. fowleri infections.

Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 16:56